A Comprehensive 19 F NMR Framework for Fragment‐Based Drug Discovery: The Validated Screening Library OpenFL600 and Efficient Affinity Ranking by CSAR
Angewandte Chemie International Edition · 21.09.2026 · 65 (39)
DOI: 10.1002/anie.9964915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 23.07.2026. Verfasst von Simon H Rüdisser und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, ETH Zürich, Zürich, Switzerland. Hauptthemen laut MEDLINE: Drug Discovery, Small Molecule Libraries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Small‐molecule drug discovery relies on the identification of initial chemical starting points, or screening hits, and their subsequent optimization for potency and selectivity. Fragment‐based drug discovery (FBDD), particularly through NMR screening, is a powerful method for hit identification due to its high sensitivity. Here, we present the design and validation of a non‐proprietary NMR screening library (OpenFL600) capable of probing diverse binding pockets, as demonstrated for RNA, G protein‐coupled receptors (GPCRs), kinases, protein–protein interactions, and proteases. Our screening campaigns yielded specific hits for 11 respective targets and therefore valuable structure–activity relationship (SAR). The absence of promiscuous binders confirms the high quality of the OpenFL600 library, a result of both careful fragment selection and rigorous molecular quality control. Subsequent affinity ranking of identified hits—typically a laborious task—is considerably streamlined by fast chemical shift anisotropy (CSA) Affinity Ranking (CSAR). CSAR is enabled by providing CSA values for each fragment. This creates a highly efficient workflow, from initial hit screening to the prioritization of leads. In summary, we provide a comprehensive framework for NMR‐based screening across diverse target classes, assessing their druggability, and enabling efficient affinity ranking to facilitate hit‐to‐lead progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, ETH Zürich, Zürich, Switzerland.
- Present address: Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, Switzerland.
- Present address: CPI Healthcare, Glasgow, United Kingdom.
- Mag-Lab, Vienna, Austria.
- Present address: CIC bioGUNE, Derio, Bizkaia, Spain.
- Resonate Bio, Vienna, Austria.
ORCID-Profile: Simon H Rüdisser, Gabriela Stadler, Giacomo Padroni, Daria Barbash, Marco M Ruckstuhl, Nils Lorz, Christina Jordan, Sarah Skibinski, Timo T Stühlinger, Sarah E Kratzwald, Sven Brüschweiler, Gerald Platzer, Antoine Cléry, Robert Konrat, Frédéric H-T Allain, Alvar D Gossert
Zitieren
APA
Rüdisser, S. H., Stadler, G., Padroni, G., Barbash, D., Ruckstuhl, M. M., Lorz, N., Jordan, C., Skibinski, S., Stühlinger, T. T., Kratzwald, S. E., Siess, K. M., Brüschweiler, S., Platzer, G., Cléry, A., Konrat, R., Allain, F. H., & Gossert, A. D. (2026). A Comprehensive 19 F NMR Framework for Fragment‐Based Drug Discovery: The Validated Screening Library OpenFL600 and Efficient Affinity Ranking by CSAR. Angewandte Chemie International Edition, 65(39). https://doi.org/10.1002/anie.9964915
Vancouver
Rüdisser SH, Stadler G, Padroni G, Barbash D, Ruckstuhl MM, Lorz N, et al. A Comprehensive 19 F NMR Framework for Fragment‐Based Drug Discovery: The Validated Screening Library OpenFL600 and Efficient Affinity Ranking by CSAR. Angewandte Chemie International Edition. 2026;65(39). doi:10.1002/anie.9964915
BibTeX
@article{Rdisser2026,
author = {Rüdisser, Simon H and Stadler, Gabriela and Padroni, Giacomo and Barbash, Daria and Ruckstuhl, Marco M and Lorz, Nils and Jordan, Christina and Skibinski, Sarah and Stühlinger, Timo T and Kratzwald, Sarah E and Siess, Katharina M and Brüschweiler, Sven and Platzer, Gerald and Cléry, Antoine and Konrat, Robert and Allain, Frédéric H-T and Gossert, Alvar D},
title = {A Comprehensive 19 F NMR Framework for Fragment‐Based Drug Discovery: The Validated Screening Library OpenFL600 and Efficient Affinity Ranking by CSAR},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {39},
doi = {10.1002/anie.9964915}
}
EUVIMED